Important data from Brazil demonstrating the safety and non inferiority of DOAC therapy in biological mitral valves and atrial fibrillation. This study makes a significant…
View More Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve
Imperial College have published an innovative study in the BCS demonstrating that adverse symptom related to statin, placebo or no treatment. The study design was…
View More N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects
Tony was a leading light of interventional cardiology for more than 35 years and a tireless advocate of the importance of trials to guide clinical practice.
View More Tony Gershlick
Dr Rebecca Dobson addresses the findings from a recent survey on why trainees don’t pursue careers in cardiology.
View More Women NOT in cardiology – where are we going wrong?
Dr Nadir Elamin, Cardiology SpR, reports on the third day of the European Society of Cardiology Congress, taking place entirely online this year due to the banning of public gatherings in the Netherlands to prevent the spread of COVID-19
View More ESC Congress 2020 – The Digital Experience
Meetings and courses to remain online during COVID-19 pandemic
View More ESC Congress 2021 to Be Held Online
Announcement on the staging of the 2021 edition of the BCS Annual Conference
View More BCS Announcement On The Annual Conference 2021
Day Two, as reported by three BCS members in attendance
View More ESC Congress 2020 – The Digital Experience
We know that across the world a billion people have high blood pressure and 10.7 million people die each year because of high blood pressure.…
View More Evidence based research on CVD prevention
Peter will be remembered as one of the leading academic cardiologists of his generation. Emeritus Professor of Cardiovascular Medicine, Oxford UniversityEmeritus Fellow, Exeter College, Oxford…
View More Peter Sleight